Harbin Gloria Pharmaceuticals Co., Ltd. logo

Harbin Gloria Pharmaceuticals Co., Ltd. (002437)

Market Closed
12 Dec, 06:57
XSHE XSHE
¥
3. 10
-0.01
-0.32%
¥
7.25B Market Cap
- P/E Ratio
0.05% Div Yield
24,724,400 Volume
- Eps
¥ 3.11
Previous Close
Day Range
3.08 3.22
Year Range
2.12 4.08
Want to track 002437 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002437 closed yesterday lower at ¥3.1, a decrease of 0.32% from Thursday's close, completing a monthly decrease of -2.21% or ¥0.07. Over the past 12 months, 002437 stock gained 25%.
002437 is not paying dividends to its shareholders.
The last earnings report, released on Oct 29, 2024, exceeded the consensus estimates by 0.03%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSHE (CNY).

002437 Chart

Similar

Sunvim Group Co., Ltd.
¥ 10.29
-6.28%
China Machinery Huanyu Co., Ltd.
¥ -
-
Tibet Gaozheng Explosive Co., Ltd.
¥ 34.95
+0.69%
Innovative Medical Management Co., Ltd.
¥ 20.98
-0.33%
Henan Liliang Diamond Co., Ltd.
¥ 36.36
-0.87%

Harbin Gloria Pharmaceuticals Co., Ltd. (002437) FAQ

What is the stock price today?

The current price is ¥3.10.

On which exchange is it traded?

Harbin Gloria Pharmaceuticals Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002437.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.05%.

What is its market cap?

As of today, the market cap is 7.25B.

Has Harbin Gloria Pharmaceuticals Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Harbin Gloria Pharmaceuticals Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Leifeng Guo CEO
XSHE Exchange
CNE100000QG8 ISIN
CN Country
2,703 Employees
- Last Dividend
3 Jun 2016 Last Split
23 Jun 2010 IPO Date

Overview

Harbin Gloria Pharmaceuticals Co., Ltd is a prominent pharmaceutical company based in Harbin, People's Republic of China. Founded in the year 2000, the company dedicates itself to the research, development, production, and sale of a wide range of pharmaceutical products within the Chinese market. Harbin Gloria Pharmaceuticals has carved a niche for itself by focusing on the creation of medications that cater to various health conditions, ranging from cardiac cerebrovascular issues to antitumor treatments. The commitment to innovation and quality has positioned the company as a key player in China's pharmaceutical industry.

Products and Services

  • Cardiac Cerebrovascular Medication: These are drugs designed to treat conditions related to the heart and blood vessels, including stroke, heart attack, and other related disorders. Harbin Gloria Pharmaceuticals offers a range of options for patients seeking treatment for cardiovascular diseases.
  • Skeletal Muscle System: This category includes medications for the treatment and management of bone, joint, and muscle conditions. Whether it's osteoporosis, arthritis, or muscle spasms, Harbin Gloria Pharmaceuticals provides solutions aimed at improving patient health and quality of life.
  • Vitamins and Minerals: Offering a variety of essential nutrients, these supplements are designed to support overall health and well-being. They cater to various nutritional deficiencies and promote better health.
  • Urinary System Medication: These medications are focused on treating diseases and disorders of the urinary system, including the kidneys, ureters, bladder, and urethra. Harbin Gloria Pharmaceuticals develops drugs to help manage conditions such as urinary tract infections, kidney stones, and bladder issues.
  • Antitumor Medication: This segment includes drugs that are used in the treatment of various types of cancer. Harbin Gloria Pharmaceuticals is involved in the development and production of antitumor drugs that target different kinds of cancer cells, striving to improve survival rates and the quality of life for patients.
  • Endocrine Medicine: These medications are designed to help balance hormones and treat endocrine disorders, including thyroid diseases, diabetes, and adrenal gland disorders. The company's endocrine medicines aim to restore harmony within the body's complex hormonal systems.
  • Anti-infective Drugs: Focused on combating infections caused by bacteria, viruses, fungi, or parasites, these medications are crucial in treating infectious diseases and preventing their spread. Harbin Gloria Pharmaceuticals offers a range of anti-infectives to address various infectious conditions.
  • Respiratory Medication: Aimed at treating diseases and disorders affecting the lungs and respiratory system, such as asthma, chronic obstructive pulmonary disease (COPD), and pneumonia. The company provides medications designed to improve breathing and manage respiratory symptoms.
  • Antihistamine: These drugs are used to treat allergic reactions, including hay fever, hives, and other allergic conditions. Harbin Gloria Pharmaceuticals offers antihistamines that help reduce or eliminate symptoms like itching, swelling, and rashes.
  • Peptic: Including medications for the treatment of peptic ulcers and related gastrointestinal conditions. Harbin Gloria Pharmaceuticals produces drugs that help manage and alleviate the discomfort caused by ulcers in the stomach and duodenum.
  • Other Products: Harbin Gloria Pharmaceuticals also offers a range of other pharmaceutical products designed to meet various health needs, contributing to their broad and diverse product portfolio.

Contact Information

Address: No. 29, Beijing Road, Harbin, China, 150025
Phone: 86 451 5735 1368